Iatrogenic immunodeficiency-associated lymphoproliferative disorder secondary to mycophenolate mofetil treatment in a patient with myasthenia gravis

Muscle Nerve. 2022 Apr;65(4):E14-E16. doi: 10.1002/mus.27485. Epub 2022 Jan 20.

Authors

Kate Zha¹, Nicholas J Silvestri²

Affiliations

¹ University at Buffalo Jacobs School of Medicine & Biomedical Sciences, Buffalo, New York, USA.
² Department of Neurology, University at Buffalo Jacobs School of Medicine & Biomedical Sciences, Buffalo, New York, USA.

PMID: 34993978
DOI: 10.1002/mus.27485

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Humans
Iatrogenic Disease
Immunologic Deficiency Syndromes* / chemically induced
Immunosuppressive Agents / adverse effects
Lymphoproliferative Disorders* / chemically induced
Myasthenia Gravis* / drug therapy
Mycophenolic Acid / adverse effects

Substances

Immunosuppressive Agents
Mycophenolic Acid